Dianthus Therapeutics Has Appreciated 13-Fold Over Two Years. What's Going On?
Dianthus TherapeuticsDianthus Therapeutics(US:DNTH) Investors·2026-03-10 00:07

公司动态 - Dianthus Therapeutics公司股价在周一大幅上涨 原因在于公司宣布将推进其治疗慢性炎性脱髓鞘性多发性神经根神经病的实验性疗法[1]

Dianthus Therapeutics Has Appreciated 13-Fold Over Two Years. What's Going On? - Reportify